Lixte Biotechnology : Termination of Material Agreement - Form 8-K

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT


PURSUANT TO... | May 10, 2023

Related Keywords

Washington ,United States ,Westpark ,California ,Colorado , ,Westpark Capital Inc ,Company Current Report On Form ,Lixte Biotechnology Holdings Inc ,Nasdaqstock Market ,Securities Exchange ,Exchange Commission On ,Colorado Blvd Suite ,General Instruction ,Securities Act ,Exchange Act ,Purchase Common ,Material Definitive ,Lixte Biotechnology Holdings ,Westpark Capital ,Sales Agreement ,Current Report ,Exchange Commission ,Securities Exchange Act ,Nc Stock Exchange ,News ,Information ,Press Release ,United ,Securities ,End ,Exchange ,Form ,Current ,Ursuant Lixt Us5393192027 ,